top of page

Parkinson's Disease

International Live Conference on

July 6, 2024
Live Conference

https://www.olcias.com/parkinson

Join us on LinkedIn for the live stream of Parkinson's Disease 2023!
Click here to join the live stream at 8 PM IST.

The International Conference on Parkinson's Disease is an annual event that aims to bring together professionals from various fields to discuss the latest advances in Parkinson's disease treatment and management. The online conference, organized by the One Live Conference for International Associations and Societies (OLCIAS), is scheduled to take place on July 6, 2024.
 

Parkinson's disease is a neurodegenerative disorder that affects millions of people worldwide. It is characterized by motor symptoms such as tremors, rigidity, and bradykinesia, as well as non-motor symptoms such as depression, anxiety, and cognitive impairment. According to the Parkinson's Foundation, around 10 million people globally are living with Parkinson's disease, and an estimated 60,000 Americans are diagnosed with the disease each year.
 

The research and development of Parkinson's disease have been an area of significant investment from governments, non-profit organizations, and pharmaceutical companies. In 2020, the National Institutes of Health (NIH) invested over $211 million in Parkinson's disease research, while the Michael J. Fox Foundation for Parkinson's Research has raised more than $1 billion to fund research into the causes and potential cures for the disease. The global Parkinson's disease treatment market size was valued at USD 2.2 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2021 to 2028, according to Grand View Research.
 

Recent research has focused on identifying biomarkers that could lead to early diagnosis of Parkinson's disease and the development of new treatments. Gene therapy-based approaches to treat Parkinson's disease are also being developed by some pharmaceutical companies.
 

Treatment for Parkinson's disease typically involves medication such as levodopa and physical therapy. In some cases, surgery may be recommended to alleviate symptoms.
 

The International Conference on Parkinson's Disease will cover a range of important topics related to the disease, including emerging therapies, advances in biomarkers for early diagnosis, non-motor symptoms, surgical approaches, and patient-centered care and support. The conference will provide an opportunity for researchers, healthcare professionals, and patient advocates to share their knowledge and experience and to discuss ways to improve care and treatment for people living with Parkinson's disease.

Title: The International Live Conference on Parkinson's Disease
Date: July 6, 2024
​Time: 8 PM Indian Standard Time
Location: Online
Conference Theme: The Future of Parkinson's Disease Research and Clinical Practice

Deadlines:

To secure your place as a distinguished speaker at this conference, ensure to submit your abstract no later than February 6, 2024.

Tracks:

  • Molecular Biology

  • Neuroanatomy

  • Neurophysiology & Electrophysiology

  • Neuropharmacology

  • Neuropsychology

  • Neuroimaging

  • Neurotoxicology

  • Clinical Phenomenology

  • Surgical and Pharmacological Treatment

  • Transplantation Studies

  • Relationship with Ageing

  • Epidemiology & Environmental Impact Factors

  • Rehabilitation

The Parkinson Pandemic: Emerging Evidence:
Parkinson disease is the neurological condition with the fastest global growth rate and is currently the main cause of disability. Over 6 million people now have Parkinson disease, up from 2 million in 1990. This number is expected to more than double to nearly 12 million by 2040, primarily due to ageing. The load could increase to nearly 17 million as a result of additional factors like longer life expectancy, a decline in smoking rates, and increased industrialization. Parkinson's disease has always been a rare condition. However, a pandemic of Parkinson's disease brought on by demography and the byproducts of industrialization will need for increased advocacy, targeted preparation, and creative strategies.

Dr. Tshetiz Dahal

Lugansk State Medical University

Ukraine

The role of insulin resistance and glucose intolerance among patients with Parkinson’s Disease:
The strongest evidence yet that diabetes can alter Parkinson's disease development has been revealed by a recent study supported by Cure Parkinson's

Diabetes is a disorder that interferes with the body's chemical processes for converting food into energy in the cells. It is brought on by issues with the insulin protein. Insulin functions as a key to unlock cells, allowing glucose to enter. Insulin is necessary for our cells to absorb glucose, which is utilized as fuel. In diabetes, glucose levels in the blood rise because insulin no longer functions correctly, preventing it from being absorbed by cells.

The link between Parkinson's disease and diabetes has long been understood by researchers. Diabetes increases the risk of Parkinson's disease development compared to non-diabetics, while Parkinson's disease increases the risk of diabetes compared to non-diabetics.

The goal of this new study was to have a better understanding of how diabetes may affect the course of Parkinson's symptoms. They analyzed patient data over a 36-month period using information from the longitudinal Tracking Parkinson's research.

This is the largest study till date to show that diabetes is linked to a quicker progression of Parkinson's symptoms; they discovered that persons with Parkinson's who also had diabetes experienced more severe motor and non-motor symptoms over time.

Sanobar Shariff

Yerevan State Medical University

Armenia

1/28
bottom of page